Virax Biolabs Group (VRAX) Stock Chart & Stock Price History $0.87 -0.06 (-6.05%) Closing price 07/15/2025 03:58 PM EasternExtended Trading$0.87 +0.00 (+0.34%) As of 07/15/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Virax Biolabs Group Stock Price Performance The Virax Biolabs Group (VRAX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 32.03%, with a year-to-date return of -61.33%. In the past month, the stock has decreased 0.03%, reflecting recent market activity. As of the latest close, Virax Biolabs Group traded at $0.87 with a market cap of $3.78 million and volume of 36,923 shares. Receive VRAX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Virax Biolabs Group and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-3.33%1 Month Performance-0.03%3 Month Performance-15.53%Year-To-Date Performance-61.33%1 Year Performance-32.03% VRAX Stock Chart for Wednesday, July, 16, 2025 VRAX Chart by TradingView Virax Biolabs Group Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/15/2025$0.93$0.87-6.05%$0.94$0.8736,923 shs$3.78 million07/14/2025$0.90$0.93+2.89%$0.98$0.85308,351 shs$4.02 million07/11/2025$0.89$0.90+1.11%$0.98$0.85210,908 shs$3.91 million07/10/2025$0.92$0.89-3.63%$0.95$0.8936,767 shs$3.86 million07/09/2025$0.87$0.92+6.60%$0.99$0.86179,486 shs$4.01 million07/08/2025$0.86$0.87+0.74%$0.88$0.8518,071 shs$2.80 million07/07/2025$0.87$0.86-0.58%$0.88$0.8481,542 shs$3.73 million07/04/2025$0.87$0.87$0.87$0.858,750 shs$2.80 million07/03/2025$0.86$0.87+0.59%$0.87$0.858,750 shs$2.79 million07/02/2025$0.83$0.86+3.85%$0.88$0.8311,732 shs$2.78 million Get the Latest News and Ratings for VRAX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Virax Biolabs Group and its competitors with MarketBeat's FREE daily newsletter. 07/01/2025$0.79$0.83+4.59%$0.85$0.7730,734 shs$2.67 million06/30/2025$0.78$0.79+1.50%$0.82$0.7491,228 shs$2.56 million06/27/2025$0.77$0.78+1.30%$0.85$0.7539,145 shs$2.52 million06/26/2025$0.76$0.77+1.32%$0.86$0.7627,224 shs$2.49 million06/25/2025$0.80$0.76-5.18%$0.85$0.7537,690 shs$2.46 million06/24/2025$0.76$0.80+5.45%$0.83$0.7836,848 shs$2.59 million06/23/2025$0.80$0.76-5.34%$0.82$0.7522,778 shs$2.46 million06/20/2025$0.81$0.80-0.99%$0.84$0.7631,989 shs$2.60 million06/19/2025$0.81$0.81$0.82$0.8033,452 shs$2.62 million06/18/2025$0.82$0.81-0.98%$0.82$0.8033,452 shs$2.62 million06/17/2025$0.87$0.82-5.89%$0.87$0.8145,760 shs$2.65 million06/16/2025$0.88$0.87-1.38%$0.93$0.8746,228 shs$2.81 million Related Companies Synaptogenix Stock Chart PHAXIAM Therapeutics Stock Chart Talphera Stock Chart Calidi Biotherapeutics Stock Chart Addex Therapeutics Stock Chart GeoVax Labs Stock Chart GlycoMimetics Stock Chart Aprea Therapeutics Stock Chart X4 Pharmaceuticals Stock Chart Cyclerion Therapeutics Stock Chart Receive VRAX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Virax Biolabs Group and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:VRAX) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhy Elon is funding the “Quantum Power Grid”Elon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virax Biolabs Group Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Virax Biolabs Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VRAX Stock Alerts